Cargando…

Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma

BACKGROUND: Disulfidptosis is independent of apoptosis, ferroptosis, and cuproptosis and is associated with cancer progression, treatment response, and prognosis. However, the predictive potential of disulfidptosis-associated lncRNAs in colon adenocarcinoma (COAD) and their features in the tumor imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Weijie, Qiu, Kang, Dong, Bingzi, Guo, Dong, Fu, Junhua, Zhu, Chengzhan, Niu, Zhaojian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523716/ https://www.ncbi.nlm.nih.gov/pubmed/37759294 http://dx.doi.org/10.1186/s12935-023-03065-8

Ejemplares similares

miRNA-Based Signature Associated With Tumor Mutational Burden in Colon Adenocarcinoma
por: Xue, Weijie, et al.
Publicado: (2021)

Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma
por: Chen, Pan, et al.
Publicado: (2023)

Characterization and Prognosis of Biological Microenvironment in Lung Adenocarcinoma through a Disulfidptosis-Related lncRNAs Signature
por: Yang, Zhuo, et al.
Publicado: (2023)

A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma
por: Hu, Gunchu, et al.
Publicado: (2023)

Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
por: Ma, Xiaoqing, et al.
Publicado: (2023)

The expression and prognostic value of disulfidptosis progress in lung adenocarcinoma
por: Ni, Lina, et al.
Publicado: (2023)

Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer
por: Dong, Xiaoqian, et al.
Publicado: (2023)

A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma
por: Zhang, Hai-Bo, et al.
Publicado: (2023)

Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation
por: Wang, Yuzhi, et al.
Publicado: (2023)

Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning
por: Zhao, Yi, et al.
Publicado: (2023)

Unraveling the role of disulfidptosis-related LncRNAs in colon cancer: a prognostic indicator for immunotherapy response, chemotherapy sensitivity, and insights into cell death mechanisms
por: Chi, Hao, et al.
Publicado: (2023)

Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022)

The disulfidptosis-related signature predicts prognosis and immune features in glioma patients
por: Wang, Xiong, et al.
Publicado: (2023)

Identification and validation of disulfidptosis-related gene signatures and their subtype in diabetic nephropathy
por: Xu, Danping, et al.
Publicado: (2023)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

A novel prognostic signature and immune microenvironment characteristics associated with disulfidptosis in papillary thyroid carcinoma based on single-cell RNA sequencing
por: Liao, Zhenyu, et al.
Publicado: (2023)

Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis
por: Xu, Kai, et al.
Publicado: (2023)

A disulfidptosis-related lncRNA index predicting prognosis and the tumor microenvironment in colorectal cancer
por: Xiao, Lijun, et al.
Publicado: (2023)

The prognostic value of lncRNA SNHG1 in cancer patients: a meta-analysis
por: Dong, Bingzi, et al.
Publicado: (2019)

A Disulfidptosis-Related Gene Signature Associated with Prognosis and Immune Cell Infiltration in Osteosarcoma
por: Chen, Pengyu, et al.
Publicado: (2023)

Anticancer Effect of Radix Astragali on Cholangiocarcinoma In Vitro and Its Mechanism via Network Pharmacology
por: Wang, Yixiu, et al.
Publicado: (2020)

Cell Sources and Influencing Factors of Liver Regeneration: A Review
por: Zhu, Chengzhan, et al.
Publicado: (2020)

Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients
por: Chen, Hualin, et al.
Publicado: (2023)

Construction of a novel disulfidptosis-related signature for improving outcomes in hepatocellular carcinoma: Observational study
por: Chen, Xi, et al.
Publicado: (2023)

A novel disulfidptosis-related immune checkpoint genes signature: forecasting the prognosis of hepatocellular carcinoma
por: Chen, Yuxin, et al.
Publicado: (2023)

The role of molecular subtypes and immune infiltration characteristics based on disulfidptosis-associated genes in lung adenocarcinoma
por: Qi, Cui, et al.
Publicado: (2023)

Development of an exosome-related and immune microenvironment prognostic signature in colon adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)

Disulfidptosis-associated LncRNAs index predicts prognosis and chemotherapy drugs sensitivity in cervical cancer
por: Liu, Li, et al.
Publicado: (2023)

Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma
por: Nan, Han, et al.
Publicado: (2023)

An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
por: Zhang, Dong, et al.
Publicado: (2023)

Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer
por: Liang, Jiahui, et al.
Publicado: (2023)

Pan-cancer Analysis of the Disulfidptosis-related Gene NCKAP1 and Its Prognostic Value for Lung Adenocarcinoma
por: Zhu, Ankang, et al.
Publicado: (2023)

Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
por: Smith, Caitlyn, et al.
Publicado: (2022)

Disulfidptosis: a new target for metabolic cancer therapy
por: Zheng, Peijie, et al.
Publicado: (2023)

Disulfidptosis: a new form of programmed cell death
por: Zheng, Tingjin, et al.
Publicado: (2023)

Identification of disulfidptosis-related genes and subgroups in Alzheimer’s disease
por: Ma, Shijia, et al.
Publicado: (2023)

Identification of an Immune Gene Signature Based on Tumor Microenvironment Characteristics in Colon Adenocarcinoma
por: Chen, Ying, et al.
Publicado: (2021)

Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects
por: Li, Ke-Yu, et al.
Publicado: (2020)

Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver disease
por: Yu, Xiaoxiao, et al.
Publicado: (2023)

Disulfidptosis-associated lncRNAs predict breast cancer subtypes
por: Xia, Qing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ujutbk9ai49nt4skv9jtri2rd2